81 FR 32754 - Advisory Committee on Immunization Practices (ACIP)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 100 (May 24, 2016)

[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Pages 32754-32755]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee.

Time and Date

8:00 a.m.-6:00 p.m., EDT, June 22, 2016
8:00 a.m.-5:00 p.m., EDT, June 23, 2016

    Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton 
Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 
30329.
    Status: Open to the public, limited only by the space available. 
Time will be available for public comment. The public is welcome to 
submit written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt June 13, 2016. All requests must contain the name, 
address, and organizational affiliation of the speaker, as well as the 
topic being addressed. Written comments should not exceed one single-
spaced typed page in length and delivered in 3 minutes or less. Please 
note that the public comment period may end before the time indicated, 
following the last call for comments. Members of the public who wish to 
provide public comments should plan to attend the public comment 
session at the start time listed. Written comments received in advance 
of the meeting will be included in the official record of the meeting.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate use of immunizing agents. In addition, under 42 
U.S.C. 1396s, the committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines. 
Further, under provisions of the Affordable Care Act, at section 2713 
of the Public Health Service Act, immunization recommendations of the 
ACIP that have been adopted by the Director of the Centers for Disease 
Control and Prevention and appear on the CDC immunization schedules 
must be covered by applicable health plans.
    Matters for Discussion: The agenda will include discussions on: 
Meningococcal vaccines; human papillomavirus vaccines; influenza; 
cholera vaccine; hepatitis vaccines; safety of maternal Tdap 
vaccination; child/adolescent immunization schedule; Respiratory 
Syncytial Virus (RSV) and vaccine supply. A recommendation vote is 
scheduled for meningococcal vaccines and cholera vaccine. A Vaccines 
for Children (VFC) vote is scheduled for meningococcal vaccines.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road, NE., MS-A27, Atlanta, Georgia 30329, telephone 404/639-8836; 
Email [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of

[[Page 32755]]

meetings and other committee management activities for both the Centers 
for Disease Control and Prevention and the Agency for Toxic Substances 
and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-12150 Filed 5-23-16; 8:45 am]
 BILLING CODE 4160-18-P